Loading...

Iofina

AIM:IOF
Snowflake Description

High growth potential with mediocre balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
IOF
AIM
£21M
Market Cap
  1. Home
  2. GB
  3. Materials
Company description

Iofina plc engages in the production of iodine, water, and natural gas in the United States and the United Kingdom. The last earnings update was 21 days ago. More info.


Add to Portfolio Compare Print
  • Iofina has significant price volatility in the past 3 months.
IOF Share Price and Events
7 Day Returns
-26.1%
AIM:IOF
-0.2%
GB Chemicals
1%
GB Market
1 Year Returns
-7.6%
AIM:IOF
-17.3%
GB Chemicals
-6.3%
GB Market
IOF Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Iofina (IOF) -26.1% 12.9% 19.3% -7.6% -4.2% -66.5%
GB Chemicals -0.2% -7.7% -4.9% -17.3% 14.8% 8.6%
GB Market 1% -1.8% 1.5% -6.3% 14.4% 2%
1 Year Return vs Industry and Market
  • IOF outperformed the Chemicals industry which returned -17.3% over the past year.
  • IOF underperformed the Market in United Kingdom of Great Britain and Northern Ireland which returned -6.3% over the past year.
Price Volatility
IOF
Industry
5yr Volatility vs Market

Value

 Is Iofina undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Iofina to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Iofina.

AIM:IOF Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 1 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 10.3%
Perpetual Growth Rate 10-Year GB Government Bond Rate 1.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for AIM:IOF
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year GB Govt Bond Rate 1.2%
Equity Risk Premium S&P Global 6.7%
Chemicals Unlevered Beta Simply Wall St/ S&P Global 0.87
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.871 (1 + (1- 19%) (93.78%))
1.357
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.36
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.23% + (1.357 * 6.65%)
10.25%

Discounted Cash Flow Calculation for AIM:IOF using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Iofina is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

AIM:IOF DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 10.25%)
2019 1.00 Analyst x1 0.91
2020 4.70 Analyst x1 3.87
2021 4.70 Analyst x1 3.51
2022 4.72 Est @ 0.37% 3.19
2023 4.75 Est @ 0.63% 2.91
2024 4.78 Est @ 0.81% 2.66
2025 4.83 Est @ 0.93% 2.44
2026 4.88 Est @ 1.02% 2.23
2027 4.93 Est @ 1.08% 2.05
2028 4.99 Est @ 1.13% 1.88
Present value of next 10 years cash flows $25.65
AIM:IOF DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= $4.99 × (1 + 1.23%) ÷ (10.25% – 1.23%)
$55.94
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $55.94 ÷ (1 + 10.25%)10
$21.08
AIM:IOF Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $25.65 + $21.08
$46.74
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $46.74 / 127.57
$0.37
AIM:IOF Discount to Share Price
Calculation Result
Exchange Rate USD/GBP
(Reporting currency to currency of AIM:IOF)
0.791
Value per Share
(GBP)
= Value per Share in USD x Exchange Rate (USD/GBP)
= $0.37 x 0.791
£0.29
Value per share (GBP) From above. £0.29
Current discount Discount to share price of £0.16
= -1 x (£0.16 - £0.29) / £0.29
43.4%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Iofina is available for.
Intrinsic value
43%
Share price is £0.164 vs Future cash flow value of £0.28966
Current Discount Checks
For Iofina to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Iofina's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Iofina's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Iofina's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Iofina's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
AIM:IOF PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $-0.01
AIM:IOF Share Price ** AIM (2019-05-22) in GBP £0.16
AIM:IOF Share Price converted to USD reporting currency Exchange rate (GBP/ USD) 1.265 $0.21
United Kingdom of Great Britain and Northern Ireland Chemicals Industry PE Ratio Median Figure of 12 Publicly-Listed Chemicals Companies 25.63x
United Kingdom of Great Britain and Northern Ireland Market PE Ratio Median Figure of 788 Publicly-Listed Companies 16.35x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Iofina.

AIM:IOF PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= AIM:IOF Share Price ÷ EPS (both in USD)

= 0.21 ÷ -0.01

-23.15x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Iofina is loss making, we can't compare its value to the GB Chemicals industry average.
  • Iofina is loss making, we can't compare the value of its earnings to the United Kingdom of Great Britain and Northern Ireland market.
Price based on expected Growth
Does Iofina's expected growth come at a high price?
Raw Data
AIM:IOF PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -23.15x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
49%per year
United Kingdom of Great Britain and Northern Ireland Chemicals Industry PEG Ratio Median Figure of 11 Publicly-Listed Chemicals Companies 1.9x
United Kingdom of Great Britain and Northern Ireland Market PEG Ratio Median Figure of 574 Publicly-Listed Companies 1.48x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Iofina, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Iofina's assets?
Raw Data
AIM:IOF PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $0.05
AIM:IOF Share Price * AIM (2019-05-22) in GBP £0.16
AIM:IOF Share Price converted to USD reporting currency Exchange rate (GBP/ USD) 1.265 $0.21
United Kingdom of Great Britain and Northern Ireland Chemicals Industry PB Ratio Median Figure of 25 Publicly-Listed Chemicals Companies 2.29x
United Kingdom of Great Britain and Northern Ireland Market PB Ratio Median Figure of 1,369 Publicly-Listed Companies 1.51x
AIM:IOF PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= AIM:IOF Share Price ÷ Book Value per Share (both in USD)

= 0.21 ÷ 0.05

4.45x

* Primary Listing of Iofina.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Iofina is overvalued based on assets compared to the GB Chemicals industry average.
X
Value checks
We assess Iofina's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check)
  5. Iofina has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Iofina expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
49%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Iofina expected to grow at an attractive rate?
  • Iofina's earnings growth is expected to exceed the low risk savings rate of 1.2%.
Growth vs Market Checks
  • Iofina's earnings growth is expected to exceed the United Kingdom of Great Britain and Northern Ireland market average.
  • Iofina's revenue growth is expected to exceed the United Kingdom of Great Britain and Northern Ireland market average.
Annual Growth Rates Comparison
Raw Data
AIM:IOF Future Growth Rates Data Sources
Data Point Source Value (per year)
AIM:IOF Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 49%
AIM:IOF Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 15%
United Kingdom of Great Britain and Northern Ireland Chemicals Industry Earnings Growth Rate Market Cap Weighted Average 7.8%
United Kingdom of Great Britain and Northern Ireland Chemicals Industry Revenue Growth Rate Market Cap Weighted Average 3.5%
United Kingdom of Great Britain and Northern Ireland Market Earnings Growth Rate Market Cap Weighted Average 11%
United Kingdom of Great Britain and Northern Ireland Market Revenue Growth Rate Market Cap Weighted Average 5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
AIM:IOF Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
AIM:IOF Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31
2022-12-31 44 10 6 1
2021-12-31 39 8 5 1
2020-12-31 35 8 4 1
2019-12-31 29 5 2 1
AIM:IOF Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 24 2 -1
2018-09-30 23 1 -5
2018-06-30 23 0 -8
2018-03-31 22 0 -9
2017-12-31 21 0 -10
2017-09-30 21 0 -7
2017-06-30 20 0 -4
2017-03-31 21 0 -4
2016-12-31 22 0 -4
2016-09-30 22 1 -4
2016-06-30 21 2 -5
2016-03-31 21 1 -4

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Iofina's earnings are expected to grow significantly at over 20% yearly.
  • Iofina's revenue is expected to grow by 15% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
AIM:IOF Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Iofina Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

AIM:IOF Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31
2022-12-31 0.03 0.03 0.03 1.00
2021-12-31 0.03 0.03 0.03 1.00
2020-12-31 0.02 0.02 0.02 1.00
2019-12-31 0.01 0.01 0.01 1.00
AIM:IOF Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 -0.01
2018-09-30 -0.04
2018-06-30 -0.07
2018-03-31 -0.07
2017-12-31 -0.08
2017-09-30 -0.05
2017-06-30 -0.03
2017-03-31 -0.03
2016-12-31 -0.03
2016-09-30 -0.03
2016-06-30 -0.04
2016-03-31 -0.03

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Iofina is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
X
Future performance checks
We assess Iofina's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Iofina has a total score of 5/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Iofina performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Iofina's growth in the last year to its industry (Chemicals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Iofina does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Iofina's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Iofina's 1-year growth to the GB Chemicals industry average as it is not currently profitable.
Earnings and Revenue History
Iofina's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Iofina Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

AIM:IOF Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 23.96 -1.14 3.66
2018-09-30 23.32 -4.80 3.63
2018-06-30 22.69 -8.45 3.60
2018-03-31 21.76 -9.09 3.53
2017-12-31 20.83 -9.73 3.46
2017-09-30 20.59 -6.62 3.77
2017-06-30 20.36 -3.51 4.08
2017-03-31 21.42 -3.59 4.02
2016-12-31 22.49 -3.66 3.97
2016-09-30 21.67 -4.18 3.17
2016-06-30 20.85 -4.70 2.36
2016-03-31 20.59 -3.84 2.87
2015-12-31 20.33 -2.98 3.37
2015-09-30 22.11 -4.40 2.33
2015-06-30 23.89 -5.81 1.29
2015-03-31 24.87 -6.23 2.30
2014-12-31 25.85 -6.65 3.31
2014-09-30 23.12 -5.79 5.14
2014-06-30 20.39 -4.92 6.96
2014-03-31 19.66 -4.33 5.95
2013-12-31 18.93 -3.74 4.95
2013-09-30 20.73 -2.01 4.20
2013-06-30 22.53 -0.29 3.45
2013-03-31 20.59 -0.71 3.47
2012-12-31 18.64 -1.13 3.50
2012-09-30 16.56 -2.04 3.57 0.10
2012-06-30 14.45 -2.95 3.63 0.21

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Iofina has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • Iofina used its assets less efficiently than the GB Chemicals industry average last year based on Return on Assets.
  • It is difficult to establish if Iofina improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Iofina's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Iofina has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Iofina's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Iofina's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Iofina is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Iofina's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Iofina's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Iofina Company Filings, last reported 4 months ago.

AIM:IOF Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 5.95 24.81 4.52
2018-09-30 5.95 24.81 4.52
2018-06-30 6.23 23.26 3.02
2018-03-31 6.23 23.26 3.02
2017-12-31 6.97 21.75 3.45
2017-09-30 6.97 21.75 3.45
2017-06-30 14.67 18.35 3.28
2017-03-31 14.67 18.35 3.28
2016-12-31 16.70 16.02 2.82
2016-09-30 16.70 16.02 2.82
2016-06-30 18.55 19.48 3.75
2016-03-31 18.55 19.48 3.75
2015-12-31 20.75 19.17 4.16
2015-09-30 20.75 19.17 4.16
2015-06-30 23.01 19.16 4.76
2015-03-31 23.01 19.16 4.76
2014-12-31 23.49 18.78 6.97
2014-09-30 23.49 18.78 6.97
2014-06-30 29.38 18.71 6.27
2014-03-31 29.38 18.71 6.27
2013-12-31 28.81 14.61 8.27
2013-09-30 28.81 14.61 8.27
2013-06-30 31.79 14.43 16.19
2013-03-31 31.79 14.43 16.19
2012-12-31 31.25 0.00 5.72
2012-09-30 31.25 0.00 5.72
2012-06-30 31.63 0.00 10.37
  • Iofina's level of debt (417.2%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (50.9% vs 417.2% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Whilst loss making Iofina has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
  • Whilst loss making Iofina has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 14.5% per year.
X
Financial health checks
We assess Iofina's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Iofina has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Iofina's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Iofina dividends.
If you bought £2,000 of Iofina shares you are expected to receive £0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Iofina's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Iofina's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
AIM:IOF Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
United Kingdom of Great Britain and Northern Ireland Chemicals Industry Average Dividend Yield Market Cap Weighted Average of 9 Stocks 2.9%
United Kingdom of Great Britain and Northern Ireland Market Average Dividend Yield Market Cap Weighted Average of 706 Stocks 4.3%
United Kingdom of Great Britain and Northern Ireland Minimum Threshold Dividend Yield 10th Percentile 1%
United Kingdom of Great Britain and Northern Ireland Bottom 25% Dividend Yield 25th Percentile 2%
United Kingdom of Great Britain and Northern Ireland Top 25% Dividend Yield 75th Percentile 5.3%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

AIM:IOF Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Iofina has not reported any payouts.
  • Unable to verify if Iofina's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Iofina's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Iofina has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Iofina's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Iofina afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Iofina has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Iofina's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Tom Becker
COMPENSATION $208,000
AGE 48
TENURE AS CEO 4.7 years
CEO Bio

Dr. Thomas Matthew Becker, also known as Tom, has been the Chief Executive Officer and President of Iofina plc since September 5, 2014. Dr. Becker served as the President of Iofina Chemical Inc., at Iofina plc, since March 2010. Dr. Becker served as the Vice President of Research and Development at H&S/Iofina Chemical. He has conducted extensive research in both inorganic and organic halogen based chemistry. Prior to H&S, Dr. Becker worked as an Oak Ridge Scholar on behalf of the US EPA and worked for various other chemical manufacturing companies. He has extensive experience in scale-up of chemical processes from laboratory to pilot to full scale production and is the inventor on several chemical patents/patent applications. He has written a magnitude of published technical papers in his career. He has been an Executive Director at Iofina plc since June 2014. Dr. Becker earned a BS in Chemistry from Indiana University and a PhD in Chemistry from the University of Cincinnati.

CEO Compensation
  • Tom's compensation has increased whilst company is loss making.
  • Insufficient data for Tom to establish whether their remuneration is reasonable compared to companies of similar size in United Kingdom of Great Britain and Northern Ireland.
Management Team Tenure

Average tenure and age of the Iofina management team in years:

4.7
Average Tenure
55.5
Average Age
  • The tenure for the Iofina management team is about average.
Management Team

Tom Becker

TITLE
CEO, President & Executive Director
COMPENSATION
$208K
AGE
48
TENURE
4.7 yrs

Malcolm Lewin

TITLE
CFO & Executive Director
COMPENSATION
$22K
AGE
67
TENURE
2.5 yrs

Simon Holden

TITLE
Company Secretary
AGE
42
TENURE
5.9 yrs

Forest Dorn

TITLE
Chief Operating Officer of Iofina Resources Inc
AGE
63
TENURE
3.3 yrs

Kurt Jones

TITLE
Chief Operating Officer of Iofina Chemical Inc
TENURE
4.7 yrs
Board of Directors Tenure

Average tenure and age of the Iofina board of directors in years:

4.9
Average Tenure
62
Average Age
  • The tenure for the Iofina board of directors is about average.
Board of Directors

Lance Baller

TITLE
Non-Executive Chairman
COMPENSATION
$108K
AGE
45
TENURE
5.1 yrs

Tom Becker

TITLE
CEO, President & Executive Director
COMPENSATION
$208K
AGE
48
TENURE
4.9 yrs

Malcolm Lewin

TITLE
CFO & Executive Director
COMPENSATION
$22K
AGE
67
TENURE
2.5 yrs

Bill Bellamy

TITLE
Non-Executive Director
COMPENSATION
$30K
AGE
70
TENURE
5.2 yrs

Jules Mermoud

TITLE
Non-Executive Director
AGE
62
TENURE
0.5 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (£) Value (£)
X
Management checks
We assess Iofina's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Iofina has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Estimating The Fair Value Of Iofina plc (LON:IOF)

This is done using the Discounted Cash Flow (DCF) model! … If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model? … We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows

Simply Wall St -

Is Iofina plc's (LON:IOF) CEO Paid At A Competitive Rate?

This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. … And finally - as a second measure of performance - we will look at the returns shareholders have received over the last few years. … How Does Tom Becker's Compensation Compare With Similar Sized Companies?

Simply Wall St -

How Should Investors Feel About Iofina plc's (LON:IOF) CEO Pay?

First, this article will compare CEO compensation with compensation at similar sized companies. … How Does Tom Becker's Compensation Compare With Similar Sized Companies. … According to our data, Iofina plc has a market capitalization of UK£17m, and pays its CEO total annual compensation worth US$208k.

Simply Wall St -

Is It The Right Time To Buy Iofina plc (LON:IOF)?

This high level of volatility gives investors the opportunity to enter into the stock, and potentially buy at an artificially low price? … A question to answer is whether Iofina's current trading price of £0.16 reflective of the actual value of the? … Let’s take a look at Iofina’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change

Simply Wall St -

Should You Buy Iofina plc (LON:IOF) Now?

Iofina plc (AIM:IOF), a chemicals company based in United Kingdom, saw significant share price volatility over the past couple of months on the AIM, rising to the highs of £0.23 and falling to the lows of £0.17. … Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. … If you believe IOF should trade below its current price, selling high and buying it back up again when its price falls towards its real value can be profitable.

Simply Wall St -

What's The Cash Runway For Iofina plc (LON:IOF)?

AIM:IOF Income Statement May 22nd 18 When will Iofina need to raise more cash? … The cash burn analysis result indicates a cash constraint for the company, due to its current level of cash reserves. … You should continue to research Iofina to get a better picture of the company by looking at: Future Outlook: What are well-informed industry analysts predicting for IOF’s future growth?

Simply Wall St -

One Thing To Consider Before Buying Iofina plc (LON:IOF)

A popular measure of market risk for a stock is its beta, and the market as a whole represents a beta value of one. … Check out our latest analysis for Iofina An interpretation of IOF's beta With a beta of 2.62, Iofina is a stock that tends to experience more gains than the market during a growth phase and also a bigger reduction in value compared to the market during a broad downturn. … How IOF's assets could affect its beta An asset-heavy company tends to have a higher beta because the risk associated with running fixed assets during a downturn is highly expensive.

Simply Wall St -

How Does Iofina plc (LON:IOF) Compare To The Basic Materials Sector?

However, this rate came in below the growth rate of the UK stock market as a whole. … Iofina lags the pack with its lower growth rate of 25.28% over the past year, which indicates the company will be growing at a slower pace than its chemicals peers. … If Iofina has been on your watchlist for a while, now may be the time to enter into the stock, if you like its growth prospects and are not highly concentrated in the chemicals industry.

Simply Wall St -

Who Are The Largest Shareholders In Iofina plc (LON:IOF)?

See our latest analysis for Iofina AIM:IOF Ownership_summary Apr 19th 18 Institutional Ownership In IOF's case, institutional ownership stands at 77.41%, significant enough to cause considerable price moves in the case of large institutional transactions, especially when there is a low level of public shares available on the market to trade. … This size of ownership, while considerably small for a public company, may not be enough to change company policy if the decision is not in sync with other large shareholders. … Thus, investors not need worry too much about the consequences of these holdings.Next Steps: IOF's considerably high level of institutional ownership calls for further analysis into its margin of safety.

Simply Wall St -

Is Iofina plc's (LON:IOF) Balance Sheet A Threat To Its Future?

How does IOF’s operating cash flow stack up against its debt? … Moreover, IOF has generated US$451.21K in operating cash flow over the same time period, resulting in an operating cash to total debt ratio of 2.82%, meaning that IOF’s current level of operating cash is not high enough to cover debt. … Maintaining a high level of debt, while revenues are still below costs, can be dangerous as liquidity tends to dry up in unexpected downturns.Next Steps: IOF’s cash flow coverage indicates it could improve its operating efficiency in order to meet demand for debt repayments should unforeseen events arise.

Simply Wall St -

Company Info

Description

Iofina plc engages in the production of iodine, water, and natural gas in the United States and the United Kingdom. It offers halogen chemicals, disinfectants, electronic specialty gases, sanitizers, heat stabilizers, preservatives, specialty intermediates, animal health, mineral separation, and odor control products for use in electronics/semiconductor, pharmaceutical, food and beverage, personal care, paints and coatings, dairy, chemical intermediates, gemological, fish and wildlife, and nylon markets. The company also provides third party brine stream operators with a turnkey mid-stream fee based solution to extract iodine. Iofina plc was founded in 2005 and is based in London, the United Kingdom.

Details
Name: Iofina plc
IOF
Exchange: AIM
Founded: 2005
£20,921,381
127,569,398
Website: http://www.iofina.com
Address: Iofina plc
48 Chancery Lane,
London,
Greater London, WC2A 1JF,
United Kingdom
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
AIM IOF Ordinary Shares London Stock Exchange AIM Market GB GBP 09. May 2008
OTCPK IOFN.F Ordinary Shares Pink Sheets LLC US USD 09. May 2008
DB IF7 Ordinary Shares Deutsche Boerse AG DE EUR 09. May 2008
Number of employees
Current staff
Staff numbers
82
Iofina employees.
Industry
Specialty Chemicals
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/22 23:53
End of day share price update: 2019/05/22 00:00
Last estimates confirmation: 2019/05/20
Last earnings filing: 2019/05/01
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.